2016 International Congress Archives - Page 96 of 207

Hydrogen sulfide functions as a neuromodulator to regulate striatal neurotransmission in a mouse model of Parkinson’s disease

L. Zhang, M. Wang, J. Zhu, Y. Pan, J. Dong (Nanjing, People's Republic of China)
Hyperekplexia secondary to cumulative novel glycine pathway mutations

S. Nandipati, S. Ceulemans, J. Friedman (La Jolla, CA, USA)
Hyperin inhibits lipopolysaccharide-induced microglia activation through p38 and NFκB signaling

X. Zhang, Y.N. Wang, H.H. Fan, R. Yang, S.Y. Li, J.H. Zhu (Wenzhou, People's Republic of China)
Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease

M. Sanoeva, N. Mansurova, A. Prokhorova (Bukhara, Uzbekistan)
Hypothalamic alpha-synuclein pathology and its relation to non-motor symptoms and disease progression in Parkinson’s disease

E. De Pablo-Fernandez, R. Courtney, J.L. Holton, T.W. Warner (London, United Kingdom)
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease

D.P. Breen, C. Nombela, R. Vuono, P.S. Jones, K. Fisher, D.J. Burn, D.J. Brooks, A.B. Reddy, J.B. Rowe, R.A. Barker (Cambridge, United Kingdom)
ICF-based effects of VIM-DBS on communication in everyday life in patients with essential tremor

M. Hartinger, M. Scholz, D. Mücke, A. Hermes, T.B. Roettger, J. Becker, M. Opitz, T.A. Dembek, I.G. Meister, V. Visser-Vandewalle, M. Grice, L. Timmermann, M.T. Barbe (Berlin, Germany)
Identification of a new biomarker in a mouse model of essential tremor using EEG

V. Duveau, B. Mandé, B. Pouyatos, Y. Roche, C. Roucard (La Tronche, France)
Identification of barriers preventing disclosure of non-motor symptoms in Parkinson’s patients to healthcare providers

C.S. Hurt, L. Rixon, K.R. Chaudhuri, R. Moss-Morris, M. Samuel, R.G. Brown (London, United Kingdom)
Identification of premotor Parkinson’s disease

K.C. Hughes, X. Gao, M.A. Schwarzschild, A. Ascherio (Boston, MA, USA)